ReviewCureus2024
Cardiovascular Disease Risk in the Obese Population in Kuwait: A Systematic Review and Meta-Analysis.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Postprandial Glycemic and Satiety Responses to Cooked Quinoa: A Randomized Crossover Preliminary Study.Foods (Basel, Switzerland) · 2026Article
- Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting-Expert Group Recommendations from Kuwait.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Review
- Burden of heart failure in Asian Countries from 1990 to 2021: Update from the Global Burden of Disease Study 2021.PloS one · 2026Article
- Older Adults' Perceptions Towards Falls and Fall Prevention in Kuwait - A Qualitative Study.Journal of frailty, sarcopenia and falls · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing prevalence of obesity and associated cardiovascular diseases (CVDs) in Kuwait requires a comprehensive analysis of its contributing factors and health outcomes. This systematic review and meta-analysis aimed to synthesize the current evidence on the relationship between obesity and CVDs and identify the main factors driving obesity in the Kuwaiti population.
methodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, multiple databases were systematically searched, identifying 980 articles. After removing duplicates and screening the articles against the inclusion criteria (observational or intervention studies published from 2001 to 2024 in English, conducted in Kuwait or on Kuwaitis, examining obesity (body mass index or validated measures) and CVDs (coronary artery disease, stroke, heart attack, hypertension, dyslipidemia, diabetes), 44 published studies from 2001 to 2024 were included in the final analysis. The studies varied widely in design and population, complicating the estimation of the total number of participants.
resultsThe pooled prevalence of overweight patients was 36% (95% CI: 25-47) with high heterogeneity (I DISCUSSION: These findings underscore the multifaceted nature of obesity in Kuwait, which is influenced by lifestyle, dietary habits, genetic factors, and socioeconomic changes. Age- and gender-specific analyses revealed higher obesity rates in adults aged 40-60 years and stronger associations with CVD in females. The consistent link between obesity and CVD risk factors highlights the urgent need for targeted public health interventions.
conclusionsObesity contributes significantly to the CVD burden in Kuwait, driven by a combination of lifestyle, genetic, and environmental factors. Comprehensive strategies addressing these determinants are essential to mitigate the obesity epidemic and its associated health risks in the Kuwaiti population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.